Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.
Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.
Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has announced its Annual Meeting of Shareholders scheduled for Thursday, June 26, 2025, at 9:00 a.m. CT. The meeting will be held in-person at 3041 Woodcreek Drive, #200, Downers Grove, IL 60515. The company has set April 28, 2025 as the record date for determining shareholders eligible to receive notice and vote at the Annual Meeting.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has announced its participation in the upcoming Planet MicroCap Showcase: VEGAS 2025. The company's presentation is scheduled for Wednesday, April 23, 2025, at 12:00 PM ET.
Executive Chairman Ray Stachowiak and CEO Gary Delanois will lead the presentation and conduct a Q&A session. The event will be held at the Paris Hotel & Casino in Las Vegas, with opportunities for 1x1 investor meetings on Thursday, April 24, 2025. Interested parties can access the live presentation through a provided webcast link, and recordings will be available on the conference platform afterward.
American Shared Hospital Services (NYSE American: AMS) reported strong financial results for FY 2024, with revenue increasing 32.9% to $28.3 million. The company's direct patient services revenue saw a remarkable 253.4% increase to $12.6 million, while leasing segment revenue decreased 12.1% to $15.6 million.
Net income attributable to AMS surged 258.4% to $2.2 million ($0.34 per diluted share) in FY 2024. Adjusted EBITDA grew 8.5% to $8.9 million. The company expanded its footprint through strategic acquisitions, including three radiation therapy centers in Rhode Island and a new facility in Puebla, Mexico.
Q4 2024 showed mixed results with revenue up 59.2% to $9.1 million, but recorded a net loss of $1.3 million due to increased reserves for impaired assets and removal costs of $2.9 million in the leasing segment.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy cancer treatment services, has scheduled its Fourth Quarter and Full Year 2024 earnings conference call for April 4th at 1:00 PM ET.
The financial results press release will be issued before market opening on April 4th. Investors can participate through:
- Domestic dial-in: 1-844-413-3972
- International dial-in: 1-412-317-5776
- Webcast: Available through www.ashs.com
A replay will be accessible until April 11, 2025, via phone (1-877-344-7529 or 1-412-317-0088, access code 2964909) and the company website.
American Shared Hospital Services (NYSE American: AMS) has received Certificate of Need (CON) approval to construct and operate a Proton Beam Radiation Treatment (PBRT) facility in Johnston, Rhode Island through its subsidiary. The facility is expected to be operational in 36-39 months, providing local access to proton therapy for Rhode Island residents who currently must travel to Boston or New York for treatment.
This development adds to AMS's existing portfolio in Rhode Island, where it holds 60% majority ownership in three photon radiation therapy facilities. The company also received a CON in April 2024 for radiation therapy services in Rhode Island's East Bay area. The PBRT facility will be the third such system in the Northeast, strategically located between New York City and Boston facilities.
American Shared Hospital Services (NYSE American: AMS) reported Q3 2024 financial results with total revenue increasing 36.3% to $6,999,000. Direct patient services revenue grew 273.2% to $3,687,000, driven by acquisitions in Rhode Island and new facility in Puebla, Mexico. However, medical equipment leasing revenue decreased 16.1% to $3,312,000 due to lower Gamma Knife volumes. The company reported a net loss of $207,000 ($0.03 per share) compared to net income of $118,000 ($0.02 per share) in Q3 2023. Adjusted EBITDA was $1,366,000, down from $1,669,000 in the prior year period.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy solutions, has scheduled its third quarter 2024 earnings conference call for November 13th at 1:00 PM ET. The financial results will be released before market opening on the same day. Investors can join via phone (domestic: 1-844-413-3972, international: 1-412-317-5776) or webcast through the company's website. A replay will be available until November 20, 2024.
American Shared Hospital Services (NYSE American: AMS) has announced key management appointments to support its growth strategy. Gary Delanois has been hired as Executive Vice President and Chief Operating Officer, bringing 28 years of healthcare management experience. Ranjit Pradhan has been promoted to Senior Vice President of Sales and Marketing, recognizing his critical role in renewing and expanding five of AMS's ten domestic Gamma Knife agreements over the past 18 months.
CEO Ray Stachowiak emphasized that these appointments align with the company's expansion plans and aim to optimize the overall business. Delanois's expertise in physician and payor relationships, as well as billing and collection procedures, is expected to contribute significantly to AMS's growth strategy. Pradhan will lead strategic marketing initiatives and drive new business growth, leveraging his extensive experience in global healthcare markets and strategic relationships.
American Shared Hospital Services (NYSE American: AMS) reported strong Q2 2024 financial results, with revenue increasing 27% year-over-year to $7.1 million. The company realized a gain of $3.7 million from the strategic acquisition of Rhode Island Radiation Therapy Cancer Centers. Net income attributable to AMS was $3.6 million, or $0.55 per diluted share, compared to a net loss of $111,000 in Q2 2023. Adjusted EBITDA increased to $2,010,000. Key highlights include:
- Gamma Knife procedures increased 10% due to strong international volume
- Proton beam radiation therapy revenue decreased 5%
- Cash at June 30, 2024 was $14.5 million
- Signed a joint venture agreement for a Gamma Knife facility in Guadalajara, Mexico
- Started patient treatments at the new Puebla, Mexico center
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy solutions, has announced its second quarter 2024 earnings conference call scheduled for August 14, 2024, at 6:30 PM ET. The company will release its Q2 2024 financial results after market close on the same day. Investors can participate in the call by dialing 844.413.3972 (domestic) or 412.317.5776 (international). A simultaneous webcast will be available on the company's website and www.streetevents.com. A replay of the call will be accessible until August 21, 2024, via phone and the company's website.
FAQ
What is the current stock price of Amer Shared Hosp (AMS)?
What is the market cap of Amer Shared Hosp (AMS)?
